Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sven de Mey"'
Autor:
Eva Reijmen, Sven De Mey, Helena Van Damme, Kirsten De Ridder, Thierry Gevaert, Emmy De Blay, Luc Bouwens, Christine Collen, Lore Decoster, Marijke De Couck, Damya Laoui, Jacques De Grève, Mark De Ridder, Yori Gidron, Cleo Goyvaerts
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The combination of radiotherapy (RT) with immunotherapy represents a promising treatment modality for non-small cell lung cancer (NSCLC) patients. As only a minority of patients shows a persistent response today, a spacious optimization window remain
Externí odkaz:
https://doaj.org/article/f583c94519e047c6b26de319c96a0fda
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Although radiotherapy is given to more than 50% of cancer patients, little progress has been made in identifying optimal radiotherapy - drug combinations to improve treatment efficacy. Using molecular data from The Cancer Genome Atlas (TCGA), we extr
Externí odkaz:
https://doaj.org/article/e50ab6e94c7f4f74ba85ba2a44e48975
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Immunotherapy, where the patient's own immune system is exploited to eliminate tumor cells, has become one of the most prominent new cancer treatment options in the last decade. The main hurdle for classical cancer vaccines is the need to identify tu
Externí odkaz:
https://doaj.org/article/3b78802ee8044633847a98bb92eb647b
Autor:
Sven de Mey, Heng Jiang, Cyril Corbet, Hui Wang, Inès Dufait, Kalun Law, Estelle Bastien, Valeri Verovski, Thierry Gevaert, Olivier Feron, Mark De Ridder
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Background and Purpose: The anti-diabetic biguanide drugs metformin and phenformin exhibit antitumor activity in various models. However, their radiomodulatory effect under hypoxic conditions, particularly for phenformin, is largely unknown. This stu
Externí odkaz:
https://doaj.org/article/ea4edf6b8e754e2b8fc6079925a303cb
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Although radiotherapy is given to more than 50% of cancer patients, little progress has been made in identifying optimal radiotherapy - drug combinations to improve treatment efficacy. Using molecular data from The Cancer Genome Atlas (TCGA), we extr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e2345465cb1e61891e2cfd037f05f93
https://hdl.handle.net/20.500.14017/b1f3d1b6-8b44-410b-8f9c-dc30c81deb62
https://hdl.handle.net/20.500.14017/b1f3d1b6-8b44-410b-8f9c-dc30c81deb62
Autor:
Hugo Vandenplas, Sven de Mey, Inès Dufait, Olivier Feron, Thierry Gevaert, Mark De Ridder, Lisa Kerkhove, Cyril Corbet, Melissa Van De Gucht, Ka Lun Law, Heng Jiang, Hui Wang
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 9367, p 9367 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 24
International Journal of Molecular Sciences
Volume 21
Issue 24
Mitochondrial metabolism is an attractive target for cancer therapy. Reprogramming metabolic pathways can potentially sensitize tumors with limited treatment options, such as triple-negative breast cancer (TNBC), to chemo- and/or radiotherapy. Dichlo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::831661300a38dea5bae02722e57bd356
https://www.mdpi.com/1422-0067/21/24/9367
https://www.mdpi.com/1422-0067/21/24/9367
Autor:
Thierry Gevaert, Pieterjan Debie, Hanne Locy, Eva Reijmen, Sandrina Martens, Cleo Goyvaerts, Kirsten De Ridder, Sven De Mey, Luc Bouwens, Jacques De Greve, Wout De Mey, Emmy De Blay, Karine Breckpot, Mark De Ridder
Publikováno v:
International journal of radiation oncology, biology, physics. 111(1)
Purpose The combination of standard-of-care radiation therapy (RT) with immunotherapy is moving to the mainstream of non-small cell lung cancer treatment. Multiple preclinical studies reported on the CD8+ T cell stimulating properties of RT, resultin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b176fb7a8c5d9a2752225288f0e6f928
https://pubmed.ncbi.nlm.nih.gov/33865948
https://pubmed.ncbi.nlm.nih.gov/33865948
Autor:
Mark De Ridder, Joeri L. Aerts, Olivier Feron, Sven de Mey, Inès Dufait, Heng Jiang, Hui Wang, Valeri N. Verovski, Thierry Gevaert, Benedikt Engels
Publikováno v:
Radiotherapy & Oncology, (2018)
The management of locally advanced rectal cancer has passed a long way of developments, where total mesorectal excision and preoperative radiotherapy are crucial to secure clinical outcome. These and other aspects of multidisciplinary strategies are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a16a186260299f611e42f1d4101124
https://doi.org/10.1016/j.radonc.2018.04.003
https://doi.org/10.1016/j.radonc.2018.04.003
Autor:
Olivier Feron, Kalun Law, Thierry Gevaert, Sven de Mey, Mark De Ridder, Cyril Corbet, Hui Wang, Heng Jiang
Publikováno v:
Cancer Letters, (2019)
Piperlongumine (PL), naturally synthesized in long pepper, is known to selectively kill tumor cells via perturbation of reactive oxygen species (ROS) homeostasis. ROS are the primary effector molecules of radiation, and increase of ROS production by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a06dcd64e18546f22c0cc412ac02692f
https://hdl.handle.net/2078.1/214232
https://hdl.handle.net/2078.1/214232
Autor:
Inès Dufait, Cyril Corbet, Mark De Ridder, Soumaya Bouzakoura, Dirk Van den Berge, Heng Jiang, Valeri N. Verovski, Thierry Gevaert, Guy Storme, Sven de Mey, Hui Wang, Olivier Feron, Kalun Law
Publikováno v:
Oncotarget
// Hui Wang 1 , Soumaya Bouzakoura 1 , Sven de Mey 1 , Heng Jiang 1 , Kalun Law 1 , Ines Dufait 1, 2 , Cyril Corbet 3 , Valeri Verovski 1 , Thierry Gevaert 1 , Olivier Feron 3 , Dirk Van den Berge 1 , Guy Storme 1 , Mark De Ridder 1 1 Department of R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::861dc4d8037cb7475c2a28015c8ad2b7
https://pubmed.ncbi.nlm.nih.gov/28415723
https://pubmed.ncbi.nlm.nih.gov/28415723